According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

Lung conditions, like asthma and chronic obstructive pulmonary disease, are more common in women than men. Stephanie Harris ...

Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in ...

COPD, or chronic obstructive pulmonary disease, affects more than 30 million Americans, yet many have never heard of it. COPD ...

A grant from the Melissa Andrews Trust has funded a software update for the Pulmonary Function Test machine (PFT) at ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that focuses on respiratory diseases, in an approximately $10 ...

Pulmonary rehabilitation is initiated and completed by a greater proportion of patients with IPF vs COPD or other chronic respiratory disorders.

If you’ve been brushing off persistent fatigue frequent headaches or unexplained weight changes your body might be telling ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Much of the Upper Midwest on Saturday was dealing with swaths of unhealthy air due to drifting smoke from Canadian wildfires, ...

A recent national study revealed ongoing symptom burden and communication gaps in COPD care, and provided physicians with ...

Background Antimicrobial resistance (AMR) is a growing global health crisis and is particularly relevant to people living ...